Commenting on the acquisition, Gregory S. Weishar, PharMerica Corporation’s Chief Executive Officer, said,"Chem Rx will operate as a separate subsidiary"

LOUISVILLE, Kentucky (November 4, 2010

and conducts business in New York State, New Jersey, Pennsylvania, and Florida. Chem Rx has been in business for over 40 years and provides prescription and non-prescription drugs, intravenous medications, durable medical equipment items and surgical supplies to approximately 60,000 patients. Commenting on the acquisition, Gregory S. Weishar, PharMerica Corporation’s Chief Executive Officer, said, “We are pleased with the acquisition of Chem Rx, which drives business scale and allows us to expand into the large New York and New Jersey markets. We believe tacquisition will create long-term shareholder value. Chem Rx brings over four decades of experience in the New York marketplace. Combined

with PharMerica’s existing scale and financial stability, Chem Rx is well positioned to continue to provide excellent service to our customers. Chem Rx will operate as a separate subsidiary, and we look forward to partnering with Jerry Silva and his management team.

) – PharMerica Corporation (NYSE: PMC), PharMerica closed on the acquisition of Chem Rx today. Chem Rx was the third largest long-term care pharmacy company in the United States